Why the study?
Hemolytic anemia following TAVR using fifth-generation SAPIEN 3 Ultra RESILIA valves was reported nationwide in Japan, but its incidence and predictors compared with third-generation SAPIEN 3 were uncharacterized.
Does the fifth-generation balloon-expandable valve increase the incidence of hemolytic anemia compared to the third-generation valve in patients undergoing transfemoral TAVR?
Does the fifth-generation balloon-expandable valve increase the incidence of hemolytic anemia compared to the third-generation valve in patients undergoing transfemoral TAVR?
The use of the fifth-generation balloon-expandable valve for TAVR is associated with a significantly higher 30-day incidence of hemolytic anemia compared to the third-generation valve.
Answers are grounded in this paper and cite their sources.
May warrant closer hemolysis monitoring with fifth-generation valves; leaves open causal confirmation in randomized TAVR trials.
BACKGROUND: Hemolytic anemia (HA) following transcatheter aortic valve replacement (TAVR) using the fifth-generation SAPIEN 3 Ultra RESILIA (S3UR) valves has been reported nationwide since its approval in Japan. OBJECTIVES: The purpose of this study was to investigate the incidence and predictors of hemolysis in fifth-generation S3UR, in comparison with third-generation SAPIEN 3 (S3). METHODS: We studied 230 consecutive patients who underwent transfemoral TAVR using S3 or S3UR between April 1, 2021, and July 31, 2024; 113 S3 and 117 S3UR. Clinically relevant HA was defined as a decline in hemoglobin of ≥2 g/dL from baseline and a nadir hemoglobin <10.0 g/dL, serum lactate dehydrogenase >500 IU/L, serum haptoglobin <10 mg/dL, reticulocyte count >2%, and no other cause of anemia, identified between postprocedure and 30-day follow-up. Incidence of HA between S3 and S3UR, and factors associated with HA in S3UR were evaluated. RESULTS: S3UR cases, compared with S3, tended to have a lower degree of paravalvular aortic regurgitation (AR); however, the incidence of HA was significantly higher (10 of 117 [8.5%; 95% CI: 4.4%-16.0%] vs 1 of 113 [0.9%; 95% CI: 0.05%-5.5%]; P = 0.006). In S3UR, severe annular calcification, chronic hemodialysis, use of 20-mm valve, no beta-blocker use, and presence of trace or mild paravalvular AR were associated with HA. However, case-based evaluation suggested that associated factors may be multifactorial. CONCLUSIONS: Incidence of HA after TAVR was higher in fifth-generation S3UR than in third-generation S3. Annular calcification, chronic hemodialysis, 20-mm size valve, no beta-blocker use, and presence of paravalvular AR were associated with HA in S3UR.
No takes yet. Share an insight, caveat, or question.
Kurashima et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: